Description
Added on the 24/02/2020 22:47:49 - Copyright : Euronews EN
On Monday, US stocks rallied as investors bet on the distribution of Pfizer's COVID-19 vaccine and stimulus progress to lift the economy. According to Business Insider, a bipartisan $908 billion stimulus proposal is set to be formally unveiled on Monday. One package will include $748 billion in funds for highly supported measures. A smaller package including more controversial state and local government aid and liability protections for businesses. On Monday, Pfizer and BioNTech will deliver their coronavirus vaccine. Oil prices ticked higher after a tanker exploded in a Saudi Arabian port. West Texas Intermediate crude gained as much as 1.9%, to $47.44 per barrel.
The closing bell rings at the New York Stock Exchange after the Dow surged past 30,000 points for the first time as receding US political uncertainty and hopes for coronavirus vaccines offset worries over spiking Covid-19 cases. After crossing the threshold in mid-day trading, the blue-chip Dow Jones Industrial Average retreated a few times throughout the afternoon before closing at 30,046.24, up 1.5 percent. IMAGES
On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%
New York (USA), Nov 9 (EFE / EPA), (Camera: Alba Vigaray).- US stocks rocketed on Monday after American pharmaceutical giant Pfizer announced that its candidate Covid-19 vaccine was 90% effective.FOOTAGE OF NEW YORK STOCK EXCHANGE
Getty Images US stocks extended losses into Monday's close as a lack of stimulus progress cut into hopes for a pre-election deal. House Speaker Nancy Pelosi expedited talks on Sunday, setting a 48-hour deadline for the White House and Democrats to ink a deal. She later told Democrats that significant obstacles in reaching a compromise remain. Even if an agreement is reached, the bill is set to die in the Senate as Republicans push a $500 billion measure. The US notched its fifth-straight day of more than 50,000 new cases, reviving fears of new lockdowns and a hit to economic recovery.